Posts for Ticker ‘SQNM’

Top Analyst Upgrades, Downgrades, Initiations (ADBE, CETV, ENER, SOLR, KR, RL, RAX, SQNM)

These are this morning’s top analyst upgrades, downgrades, and initiations seen early this Tuesday morning from Wall Street research calls:

Adobe Systems Inc. (NASDAQ: ADBE) Raised to Buy at Janney Montgomery Scott.
Central Euro Media Enterprises Ltd. (NASDAQ: CETV) Raised to Buy at Goldman Sachs.
Energy Conversion Devices, Inc. (NASDAQ: ENER) Cut to Sell at Citigroup; Cut to Neutral at JPMorgan; Cut to Hold at Lazard.
GT Solar International, Inc. (NASDAQ: SOLR) Cut to Underweight at Piper Jaffray.
Kroger Co. (NYSE: KR) Raised to Conviction Buy List at Goldman Sachs.
Polo Ralph Lauren Corp. (NYSE: RL) Raised to Conviction Buy List at Goldman Sachs.
Rackspace Hosting, Inc. (NYSE: RAX) Raised to Outperform at Oppenheimer; Raised to Buy at Kaufman
Sequenom Inc. (NASDAQ: SQNM) Maintained Sell and $3 target at Auriga.

You can join our open email distribution list to get updates on top analyst upgrades and downgrades, top day trader alerts, IPO’s, secondary offerings, Warren Buffett and other guru activity, M&A and more.

JON C. OGG

Posted on: November 10, 2009 – 7:35 am in Analyst Calls, Pre-Market Activity, , , , , , , ,

Top 10 Earnings on Deck This Week (ERTS, ENER, PCLN, SQNM, TYC, AMAT, M, JWN, WMT, DIS)

bull-and-bear-image2Earnings season has wound down now with over 85% of the S&P 500 Index having reported.  Still, there are some key companies posting their quarterly results and some companies were screened out of this list which are still actively traded or widely held stocks.  Electronic Arts Inc. (NASDAQ: ERTS), Energy Conversion Devices, Inc. (NASDAQ: ENER), Priceline.com Inc. (NASDAQ: PCLN) and Sequenom Inc. (NASDAQ: SQNM) are on deck Monday. Also this week are earnings from Tyco International Ltd. (NYSE: TYC), Applied Materials Inc. (NASDAQ: AMAT), Macy’s, Inc. (NYSE: M), are Nordstrom Inc. (NYSE: JWN). Wal-Mart Stores, Inc. (NYSE: WMT) and Walt Disney Co. (NYSE: DIS) are our two DJIA components reporting this week.

We have included Thomson Reuters consensus estimates and included performance and other important color where applicable.  We have shown the share performance since the March 9 close that traders mark as the official end date of the bloody bear market.  One issue to consider is that we used the performance since June 30 to keep consistency for our prior previews even though some of the quarter-ends this coming week are technically August 31.
Read More »

Posted on: November 8, 2009 – 10:26 am in Alternative Energy, Calendar, Cult Stock, Earnings, Green Biz, Retail, Semiconductor, Short Interest, , , , , , , , , ,

Today’s Best Market Rumors (10/9/2009)

Bull and Bear ImageUpdated throughout the day.

Updated 2:00 PM EST: American Superconductor Corporation (NASDAQ: AMSC) has traded higher all day and some are noting takeover chatter on this one.  We have yet to see anything credible, but this is up close to 4% at $32.60.

Updated  11:57 AM EST  McGraw-Hill (NYSE:MHP) may be close to selling BusinessWeek and would only keep the brand and website. All editor staff members would be let go.  (WWD)

Updated  11.47 AM EST  Riverbed (NASDAQ:RVBD) may be a takeover target for Juniper (NASDAQ:JNPR)  (Barron’s )

Updated 11.44 AM EST  GE (NYSE:GE) and Comcast (NASDAQ:CMCSA) are still in talks about NBCU with a target for a decision in three weeks.  (CNBC)

Update 11:00… Sequenom Inc. (NASDAQ: SQNM) is up another 9% today at $3.64.  The trader chat is that management and employees may have had no wrongdoing in the botched test data.  This is also not the first day of this, and we are not prepared to pan it or endorse it as it seems too soon.

Real estate developer Young Woo stands to make millions off his purchase of the AIG (NSYE:AIG) building  (TheDeal)

The FDIC is questioning the results of a review of the Citigroup (NYSE:C) management team.  (WSJ)

Chinese firm Sichuan Tengzhong could buy Hummer from GM as early as today (MarketWatch)

Vivendi will sell its 20% of NBCU, probably to GE (NYSE:GE) (The Street)

Sales of the Apple (NASDAQ:AAPL) iPhone and iPod are causing global  flash memory shortages. (AppleInsider)

Charges against two former Bear Stearns executives could hurt JPMorgan’s (NYSE:JPM) bottom line (Fortune)

IRS workers may have had a role in questionable refunds. (Forbes)

The US may start an antitrust probe into the Live Nation (LYV) merger with TicketMaster (TKTM)  (DealBook)

Douglas A. McIntyre

Posted on: October 9, 2009 – 9:19 am in Rumors, Uncategorized, , , , , , , ,

Top Day Trader Alerts (AA, CENX, DDSS, DRYS, SQNM)

These are this morning’s top day trader and active stock alerts for Thursday.  We have more detailed analysis and price/volume information with a link through to each over at VSInvestor.com:

We have provided some longer-term support and resistance levels for Alcoa Inc. (NYSE: AA) now that its shares are hitting near-term highs after earnings.

Century Aluminum Co. (NASDAQ: CENX) is acting like a leveraged Alcoa based on its trading up 10%.  You can also see how most of the related metals stocks followed Alcoa higher last night.

Labopharm Inc. (NASDAQ: DDSS) is having a repeat gain after yesterday’s pop.

DryShips, Inc. (NASDAQ: DRYS) is back on the pre-market most active movers list.

Sequenom, Inc. (NASDAQ: SQNM) is continuing its mystery rally, despite the risks of implosion.

  • Here is some trading color on Universal Display Corporation (NASDAQ: PANL) after its late-day run on Wednesday.

You can join our open email distribution list to get updates each morning on top day trader alerts, analyst upgrades and downgrades, IPO’s and secondary offerings, Warren Buffett and other guru activity, M&A and more.

JON C. OGG
October 8, 2009

Posted on: October 8, 2009 – 9:11 am in After-Hours Activity, Pre-Market Activity, Trading Alert, , , , ,

Today’s Best Market Rumors (9/29/2009) (AMD)(GOOG)(AMGN)

newspaperUpdated throughout the day.

Update:  Xerox (XRX) may find that IBM (IBM) or HP (HPQ) outbid it for ACS (ACS)  (Barron’s)

Update:  Apple (AAPL) may be working on a touchscreen remote for an upcoming TV product.  (The Boy Genius Report)

Update: Sequenom (SQNM) is recovering some losses, perhaps due to rumors it may be sold (TheStreet)

Warner Music (WMG) may be near a licensing deal with Google’s (GOOG) YouTube. (WSJ)

Hedge fund manager John Paulson may try to merge CIT (CIT) with IndyMac Federal Bank (NYPost)

Cytokinetics (CYTK) continues to rise despite denying rumorsthat it may be bought by Amgen (AMGN) (DJ Newswires).

AMD (AMD) could be at riskfor bankruptcy. (MarketWatch)

Alexion Pharmaceuticals (ALXN) and Vertex Pharmaceuticals (VRTX) may be acquisition targets.  (The Deal)

Douglas A. McIntyre

Posted on: September 29, 2009 – 9:13 am in Rumors, , , , , , , , , , , , , ,

Big Stock Moves Of The Day (9/29/2009)

Aocording to Volume Spike Investor, several stocks are making significant moves before the open.

Including in the list are Gannett (GCI) (details), BSD Medical (BSDM) (details), Walgreen (WAG) (details), Sequenom (SQMN) (details), and MBIA (MBI) (details).

Douglas A. McIntyre

Posted on: September 29, 2009 – 8:28 am in Pre-Market Activity, , , , ,

Media Digest 9/29/2009 Reuters, WSJ, NYTimes, FT, Bloomberg

newspaperReuters:   China may hold the key to a sanctions program against Iran.

Reuters:   The head of the AIG (AIG) unit that caused most of the firm’s losses is back in US.

Reuters:   The G20 has set up a long struggle over bank capital rules. Read More »

Posted on: September 29, 2009 – 4:05 am in Press Digest, , , , , , , , , , , , , , , ,

Top Day Trader Alerts (AIG, CMED, FNM, FRE, NVAX, RMBS, SQNM)

These are this Tuesday’s top day trader and active trader alert stocks.  We have links through to each with more detailed price/volume analysis over at VSinvestor.com:

American International Group, Inc. (NYSE: AIG) is getting hit again, but this time on a brokerage firm downgrade.

China Medical Technologies, Inc. (NASDAQ: CMED) is down on fairly active volume after it announced that revenues rose 29% but the net loss or earnings were down over 90%.

Fannie Mae (NYSE: FNM) and Freddie Mac (NYSE: FRE) are seeing a second morning of selling with most other speculative financial stocks.

Novavax, Inc. (NASDAQ: NVAX) is hitting 52-week highs on positive flu study data.

Rambus Inc. (NASDAQ: RMBS) continues the selling this morning after after-hours selling on unconfirmed data.

SEQUENOM Inc. (NASDAQ: SQNM) is trading lower and giving back much of Monday’s gain since no news has hit regarding its Down’s test….

If you wish to be notified by email when the top day trader alerts hit, along with news of IPO’s, key offerings, guru investor data on Buffett and others, mergers, and more, you can join our open email distribution list which goes out several times per week.

JON C. OGG

Posted on: September 1, 2009 – 8:53 am in Pre-Market Activity, Trading Alert, , , , , , ,

Top Day Trader Alerts (AIG, CROX, SQNM, LEAP, PMI, NVDA)

These are this morning’s top day trader and active stock alerts.  We have more detailed price and volume analysis links on each stock from VSInvestor.com:

American International Group (NYSE: AIG) is continuing the recent surge.  It actually made money from operations, and shares are up above $25.00 on the news.

Crocs, Inc. (NASDAQ: CROX) is almost hard to imagine as the top winner this morning.  But it is thanks to smaller losses, better guidance, and a call to return to profits.

Sequenom, Inc. (NASDAQ: SQNM) is getting shelled by 14% after losses and projections for more losses.

Leap Wireless (NASDAQ: LEAP) is one of the worst performers this morning after wider losses were reported.

PMI Group Inc. (NYSE: PMI) is getting shelled.  We have shares down over 20% in early trading after wider losses.

NVIDIA Corporation (NASDAQ: NVDA) was last night’s second highest in volume. This is on a return to profitability a quarter sooner than expected.

JON C. OGG
AUGUST 7, 2009

Posted on: August 7, 2009 – 9:16 am in Pre-Market Activity, Trading Alert, , , , , ,

SEQUENOM’s Next Wave of Issues: Lawyers (SQNM)

burning-money-pic1Sequenom, Inc. (NASDAQ: SQNM) is trading higher today after the huge implosion yesterday.  With a short interest of close to 30% of its whole float and with day traders and bottom-fishers getting in the stock, the gains we are seeing are probably not a huge shock to anyone.  But the company has severely hurt  its credibility, and the lawyers are already coming after it.
Read More »

Posted on: May 1, 2009 – 9:43 am in Biotech, Medical,

Implosion Alert: SEQUENOM, Lessons of Destroyed Credibility (SQNM)

burning-money-pic33SEQUENOM, Inc. (NASDAQ: SQNM) looks like the newest implosion of a hopeful company.  The company was supposed to have the Holy Grail for detection of Down syndrome.  After yesterday’s close, the company announced that its expected launch of its SEQureDx™ Down syndrome test was delayed.   The net effect is far worse than that.  And then some.
Read More »

Posted on: April 30, 2009 – 8:33 am in Biotech, Cult Stock, Medical, Trading Alert,

Top Analyst Upgrades (BCS, IDTI, JNY, NTES, POR, SQNM, TRMB, UEC)

These are some of the top pre-market analyst upgrades and positive research calls we have seen from Wall Street early this Wednesday morning:

Barclays (BCS) Raised to Overweight at HSBC.
Integrated Device Tech (IDTI) Raised to Buy at Deutsche Bank.
Jones Apparel (JNY) Raised to Buy at Lazard.
Netease.com (NTES) Started as Outperform at Bernstein.
Portland General Electric (POR) Raised to Overweight at Barclays.
Sequenom (SQNM) Started as Buy at Auriga.
Trimble Navigation (TRMB) Raised to Buy at Needham.
Uranium Energy Corp. (UEC) Raised to Sector Perform at RBC.

JON C. OGG

Posted on: April 29, 2009 – 6:51 am in Analyst Calls, , , , , , , ,

Top Analyst Upgrades (ABMD, ALTR, SNP, JCI, MDAS, SQNM, ZNT)

money-stack-image24These are some of the top analyst upgrades and positive research calls we are seeing this Thursday morning with about two hours until the market opens:

  • Abiomed (ABMD) Raised to Hold at Jefferies.
  • Altera (ALTR) Started as Buy at Piper Jaffray.
  • China Petroleum (SNP) Raised to Buy at UBS.
  • Johnson Controls (JCI) Raised to Buy at Deutsche Bank.
  • MedAssets (MDAS) STarted as Buy at ThinkEquity.
  • Sequenom (SQNM) Started as Outperform at JMP Securities.
  • Zenith National Insurance (ZNT) Started as Buy at Sun Trust Robinson Humphrey.

JON C. OGG

Posted on: March 12, 2009 – 6:51 am in Analyst Calls, , , , , , ,

Top Pre-Market Analyst Downgrades (ADM, CPX, DLTR, NOC, OKE, SQNM, STI, WINN, WYNN)

Burning_money_picThese are some of the top analyst downgrades and negative calls we are seeing from Wall Street this Wednesday morning:

  • Archer Daniels Midland (ADM) Cut to Neutral at JPMorgan.
  • Complete Production (CPX) Cut to Perform at Oppenheimer.
  • Dollar Tree (DLTR) Cut to Neutral at JPMorgan.
  • Northrup Grumman (NOC) Cut to Hold at Societe Generale.
  • ONEOK (OKE) Cut to Underperform at RBC.
  • Sequenom (SQNM) Cut to Perform at Oppenheimer.
  • SunTrust (STI) Cut to Neutral at Baird.
  • Winn-Dixie Stores (WINN) Started as Underperform at Jefferies.
  • Wynn Resorts (WYNN) Cut to Underweight at KeyBanc.

Jon C. Ogg
February 4, 2009

Posted on: February 4, 2009 – 7:57 am in Analyst Calls, , , , , , , , ,

Sequenom Holds Up Well On Secondary Offering (SQNM)

Sequenom, Inc. (NASDAQ: SQNM) has priced its public secondary offering of 5,500,000 shares of common stock at a price of $15.50 per share, and underwriters have a 30-day option to purchase up to an additional 825,000 shares of common stock t cover over-allotments.

Lehman Brothers and UBS Investment Bank were the joint book-running managers and co-managers for were listed as Leerink Swann, Lazard Capital Markets, Oppenheimer, and Rodman & Renshaw.

All of the shares are being offered by Sequenom and the net proceeds from the offering are earmarked for the development of diagnostic tests for use on its MassARRAY system and other platforms, and for general corporate purposes.

Shares are only down about 1.5% at $15.70 in early trading.  Shares closed at $15.94 yesterday and the 52-week trading range is $4.25 to $16.89.  Its market cap before any extra shares was listed as $723 million based on yesterday’s close.

Jon C. Ogg
June 26, 2008

Posted on: June 26, 2008 – 8:03 am in Biotech, Secondary Offering,

The Week’s Top Biotech Movers For Next Week (TRCA, ACOR, ISPH, ONCY, PCYC, SQNM, IDEV, LGND, AUXL)

Out of the daily movers this last week, many of the top winners and losers were from news in many of the smaller biotech stocks.  We prepared a list of the winners and sinners from our daily review at BioHealthInvestor.com and gave a summary regarding the moves on each.  It is becoming more obvious that many small and mid-sized biotechs are going to be gobbled up by European or Asian biotech and pharma companies seeking the dollar-discount right now.

For starters, we ran a summary of the key moving pieces out of the American Society of Clinical Oncology (ASCO).  No review would be complete without it. Stocks covered: (AVAN, PFE, CELG, IMCL, DNA)

ACQUISITION NEWS
Tercica, Inc. (NASDAQ: TRCA) bites the dust as its own company the latest small cap biotech received a huge premium acquisition from a foreign buyer, with a 104% premium.  FULL DETAILS

MAJOR WINNERS
Acorda Therapeutics Inc. (NASDAQ: ACOR) had a great week after it announced positive data from a second Phase III study of its Fampridine-SR for patients’ walking abilities in MS patients.  FULL DETAILS

Inspire Pharmaceuticals Inc. (NASDAQ: ISPH) surged after reaching its primary endpoint in Phase III trial of Denufosol for Cystic Fibrosis.  FULL DETAILS

Oncolytics Biotech Inc. (NASDAQ: ONCY) gained after the Canadian biotech’s positive Phase II studies of intravenous REOLYSIN® in patients with sarcomas metastatic to the lung.  FULL DETAILS

Pharmacyclics Inc. (NASDAQ: PCYC) gained after its Phase 1/2 trial of motexafin gadolinium plus antibody targeted radiation therapy showed a high complete response rate in patients with non-Hodgkin’s lymphoma.  FULL DETAILS

Sequenom Inc. (NASDAQ: SQNM) surged after it announced its progress with a non-invasive technology that detects Down syndrome. FULL DETAILS

MAJOR LOSERS
Indevus Pharmaceuticals Inc. (NASDAQ: IDEV) tanked after an FDA request should cause a two-year delay in approving NEBIDO.  FULL DETAILS

MIXED REVIEW
Ligand Pharmaceuticals Inc. (NASDAQ: LGND) is one we gave a full pro and con review covering the upside of the stock and the negative side of the stock.  FULL DETAILS

Auxilium Pharmaceuticals Inc. (NASDAQ: AUXL) was a strange stock this week.  The company reported great news but shares slid before the market figured out it had misinterpreted news in the company.  INITIAL DETAILS

Jon C. Ogg
June 7, 2008

Posted on: June 7, 2008 – 6:01 am in Biotech, The Week, , , , , , , , ,

Biotech Business Daily (ANIK, ATHX, HALO, IDRA, MRK, OMPI, REGN, DDD, SQNM)

There are lots of names moving in biotech and related fields today, and below are some of the top movers:

Anika Therapeutics Inc. (NASDAQ: ANIK) moving up after reporting solid first quarter earnings this morning. The leader in tissue protection products and healing and repair based on hyaluronic acid (“HA”) technology showed double digit revenues in each product line for total revenue growth of 39%. Shares are up over 12% at $9.68. The 52-week range is $7.85 to $22.49.

Athersys, Inc. (NASDAQ: ATHX) dropping a whopping 23% today on no relevant news. Shares are down $0.70 to $2.30. The 52-week range is $1.55 to $10.00.

Halozyme Therapeutics, Inc. (NASDAQ: HALO) up over 8% to $5.37. They announced that first quarter earnings will be released May 8 after market close and on May 9 they will provide a pipeline update. The 52-week range is $4.19 to $11.00.

Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) announced today that under its collaboration agreement with Merck (NYSE: MRK), they achieved a preclinical milestone with a novel Toll-Like Receptor 9 agonists for an adjuvant in cancer vaccines. Idera should receive a milestone payment from Merck. Idera is up 3% to $14.34 off a 52-week range of $6.21 to $14.00. Merck is up over 1% to $38.77 on a 52-week range of $ 36.80 to $61.62. 

Obagi Medical Products, Inc. (NASDAQ: OMPI) is up over 7% to $8.62 on now news. The 52-week range for the skincare developer is $6.80 to $25.60.

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) up 5% today after first quarter results were released this morning. They showed a loss of $11.6 million, or $0.15 EPS, narrower than the $29.9 million loss in first quarter 2007. Shares are up $1.11 to $20.73. The 52-week range is $13.55 to $28.74.

SCOLR Pharma Inc. (AMEX: DDD) up over 8% today after announcing that it entered into a lease buyout deal to move into a cheaper location, with the proceeds of over $4 million, the company said it will be able to fund 2009 expenses. Shares are trading at $1.26. The 52-week range is $0.13 to $4.07.

Sequenom Inc. (NASDAQ: SQNM) up today after reporting financial results after close yesterday. They posted a net loss of $8.6 million compared to a loss of $3.8 million in first quarter last year. Revenues increased by 7%. Shares are trading up over 8% to $6.85 on a 52-week range of $3.16 to $11.63.

Rachel Lopez
May 1, 2008

Posted on: May 1, 2008 – 1:58 pm in Biotech, , , , , , , , ,

Biotech Monday (CRIS, CGRB, EXEL, MNKD, PDLI, SQNM, TCM)

Curis Inc. (NASDAQ: CRIS) shares down 18% after development partner Wyeth terminated their contract that focused on cancer treatment developments. Shares are down $0.29 to $1.14. The 52 week range is $0.86 to $2.35.

Cougar Biotechnology, Inc. (NASDAQ: CGRB) down 23% to $17.75.

Exelixis (NASDAQ: EXEL) hit a new 5 year low this morning. Its down 7% to $5.38 on a 52 week low of $5.67 to $12.77.  No special reason for the downturn aside from a market wide lack of interest in developmental-stage drugs.

MannKind Corp. (NASDAQ: MNKD) downgrades and fears of ending inhaled insulin development lead to a new all-time low. Shares are down 18% at $4.52 in mid-day trading. The 52 week range is $5.25 to $15.99.

PDL BioPharma (NASDAQ: PDLI) fell another 8% after the recent drops after it canceled its sale last week.  Its shares hit lows of $10.12, another 52-week low.

Sequenom Inc. (NASDAQ: SQNM) down 17% on no new news. Shares are trading at  $5.47  with a  52 week range of $2.93 to $11.63.

Tongjitang Chinese Medicines Co. (NYSE: TCM) shares are up over 33% to $8.83 in mid-day trading on news that the CEO and another board director submitted a proposal to acquire all outstanding shares and take the company private. The 52 week range is $6.57 to $12.88.

Rachel Lopez
March 10, 2008

Posted on: March 10, 2008 – 2:25 pm in Biotech, , , , , , ,

Pre-Market Stock News (June 27, 2007)

(ANDW) Andrew Corp being acquired for $15.00 per share.
(APOG) Apogee Enterprises $0.34 EPS vs $0.23e; unsure if comparable.
(AUTH) AuthenTec priced its 7.5M share IPO at the top of the $9.00 to $11.00 range for 7.5 million shares.
(BAY) Bayer AG and Onyx submit supplemental new drug application for Nexavar to treat liver cancer.
(CTV) Commscope raised guidance.
(GTRC) Guitar Center being acquired by Bain Capital for $63.00 per share.
(ISTA) ISTA Pharmaceuticals will raise $36.75 million in private placement.
(JSDA) Jones Soda announced exclusive formula use pact in Japan.
(KVHI) KVH Industries announced that Monaco Coach will add the KVH TracVision R-series of mobile satellite TV systems to their new 2008 vehicles.
(NKE) Nike $0.86 EPS vs $0.86e.
(NUVO) Nuvelo lost Bayer as R&D partner in stroke trials.
(ORCL) Oracle $0.37 EPS vs $0.35e.
(PAYX) Paychex reports earnings after close: $0.36 EPS and $496.3M revenue expected.
(RYAAY) Ryanair blocked by EU in bid to buy Aer Lingus.
(SCOR) comScore priced its 5.3 million share IPO at $16.50 per share.
(SMSC) $0.29 EPS vs $0.25e.
(SQNM) Sequenom announced it will develop HPVtest and other diagnostics with SensiGEn LLC.
(TASR) Taser announced a suit in St. Louis against the company was voluntarily dismissed.
(TOPP) Topps Co. said Upper Deck has initiated a $10.75 per share tender.
(YMI) YM BioSciences received FDA Clearance for an IND for its fentanyl-based pain product.
(YUM) Yum! Brands trades ex-split to reflect a 2-1 stock split.

Jon C. Ogg
June 27, 2007

Jon Ogg can be reached at jonogg@247wallst.com; he does not own securities in the companies he covers.

Posted on: June 27, 2007 – 7:06 am in Pre-Market Activity, , , , , , , , , , , , , , , , , , , , ,